IDSA recommends shorter antibiotic courses for adults with cUTIs who show clinical improvement on effective therapy.

Credit: Getty Images Researchers conducted a systematic literature review to examine the prevalence of and risk factors for multidrug resistant infections in patients with urinary tract infections.

Cefepime-taniborbactam was 22% more effective than meropenem, which is a current treatment for complicated urinary tract infections (UTIs) and acute pyelonephritis, according to a study published in ...

A study published in Clinical Infectious Diseases examined independent predictors for treatment failure among patients with complicated urinary tract infections. Researchers conducted a multicenter ...

Compared with meropenem, cefepime-taniborbactam is superior for microbiologic and clinical cure of complicated urinary tract infection, including acute pyelonephritis. Cefepime-taniborbactam is more ...

Based on these findings, the Independent Data Monitoring Committee recommended the trial stop early. Topline data were announced from a phase 3 trial evaluating tebipenem pivoxil hydrobromide (HBr) in ...

In a recent study published in npj Antimicrobials and Resistance, researchers developed and validated interpretable machine learning (ML) algorithms that predict antibiotic resistance in complicated ...

Exblifep is a combination product that consists of cefepime, a cephalosporin antibacterial, and enmetazobactam, a beta-lactamase inhibitor. The Food and Drug Administration (FDA) has approved Exblifep ...

In January 2025, Wockhardt announced that ZAYNICH demonstrated unprecedented efficacy in a global, pivotal Phase III study ...

IRVINE, Calif., May 2, 2023 /PRNewswire/ -- Pathnostics, a leading precision diagnostic testing and development company, today announced publication of data from the Company's interim analysis for a ...

Ahead of an Antimicrobial Drugs Advisory Committee meeting on Monday, FDA reviewers voiced ongoing concerns about the benefits versus risks of a novel oral antibiotic for the treatment of ...